Phenotype of asthma related with high serum periostin levels

[ABSTRACT] Background: Asthma is a heterogeneous disease composed of various phenotypes. Periostin, a molecule inducible with interleukin (IL)-4 or IL-13 in bronchial epithelial cells, is a biomarker of "TH2-high" asthma. The objective of this study is to examine whether the serum periosti...

Full description

Saved in:

Bibliographic Details
Published in:	Allergology International Vol. 64; no. 2; pp. 175 - 180
Main Authors:	Masako Matsusakaa, Hiroki Kabataa, b, Koichi Fukunagaa, Yusuke Suzukia, Katsunori Masakia, Takao Mochimarua, Fumio Sakamakic, d, Yoshitaka Oyamadae, Takashi Inouef, Tsuyoshi Ogumab, g, Koichi Sayamab, Hidefumi Kohh, i, Morio Nakamurad, j, Akira Umedak, Junya Onol, Shoichiro Ohtam, Kenji Izuharan, Koichiro Asanoa, Tomoko Betsuyakua
Format:	Journal Article
Language:	Japanese
Published:	JAPANESE SOCIETY OF ALLERGOLOGY 01-04-2015
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	[ABSTRACT] Background: Asthma is a heterogeneous disease composed of various phenotypes. Periostin, a molecule inducible with interleukin (IL)-4 or IL-13 in bronchial epithelial cells, is a biomarker of "TH2-high" asthma. The objective of this study is to examine whether the serum periostin concentrations are correlated with the severity, specific phenotype(s), or comorbidity of asthma. Methods: Serum concentrations of periostin were measured in 190 Japanese asthmatic patients and 11 healthy controls. The protocol was registered under UMIN 000002980 in the clinical trial registry. Results: The serum concentrations of periostin were significantly higher (P=0.014) in asthmatics [70.0 (54.0-93.5) ng/ml] than in healthy subjects [57.0 (39.0-63.0) ng/ml], though we found no correlation between serum periostin concentrations and treatment steps required to control asthma. To characterize "high-periostin" phenotype(s), the patients with asthma were divided among tertiles based on the serum concentrations of periostin. The high-periostin group was older at onset of asthma (P=0.04), had a higher prevalence of aspirin intolerance (P=0.04) or concomitant nasal disorders (P=0.03-0.001), higher peripheral eosinophil counts (P<0.001), and lower pulmonary function (P=0.02-0.07). The serum concentrations of periostin were particularly high in asthmatic patients complicated by chronic rhinosinusitis with nasal polyps and olfactory dysfunction. In contrast, neither atopic status, control status of asthma, nor quality of life were related with the "high-periostin" phenotype. Conclusion: Elevated periostin concentrations in serum were correlated with a specific phenotype of eosinophilic asthma, late-onset and often complicated by obstructive pulmonary dysfunction and nasal disorders.
ISSN:	1323-8930